Sexually Transmitted Infections in Transgender and Gender-Diverse Individuals: Review of Screening and Treatment Recommendations (Q28211): Difference between revisions
Jump to navigation
Jump to search
Superraptor (talk | contribs) (Created a new Item) |
Superraptor (talk | contribs) (Added [en] label: Sexually Transmitted Infections in Transgender and Gender-Diverse Individuals: Review of Screening and Treatment Recommendations) |
||
| label / en | label / en | ||
Sexually Transmitted Infections in Transgender and Gender-Diverse Individuals: Review of Screening and Treatment Recommendations | |||
Revision as of 20:54, 1 November 2024
No description defined
- Sexually Transmitted Infections in Transgender and Gender-Diverse Individuals: Review of Screening and Treatment Recommendations.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sexually Transmitted Infections in Transgender and Gender-Diverse Individuals: Review of Screening and Treatment Recommendations |
No description defined |
|
Statements
Transgender and gender-diverse individuals experience disproportionately high rates of sexually transmitted infections (STIs). (English)
Copyright © 2024 Elsevier Inc. All rights reserved. (English)
2024
In this review, the authors discuss the epidemiology, screening recommendations, and treatment guidelines for STIs in transgender and gender-diverse people. (English)
Copyright © 2024 Elsevier Inc. All rights reserved. (English)
2024
Kristy (English)
Borawski (English)
K
Sherry S (English)
Ross (English)
SS
30 September 2024
30 September 2024
Disclosures The authors do not have any disclosures. (English)